[go: up one dir, main page]

ES2082507T5 - Composiciones de aerosol presurizado. - Google Patents

Composiciones de aerosol presurizado.

Info

Publication number
ES2082507T5
ES2082507T5 ES92920611T ES92920611T ES2082507T5 ES 2082507 T5 ES2082507 T5 ES 2082507T5 ES 92920611 T ES92920611 T ES 92920611T ES 92920611 T ES92920611 T ES 92920611T ES 2082507 T5 ES2082507 T5 ES 2082507T5
Authority
ES
Spain
Prior art keywords
pressurized aerosol
compositions
units
hydrofluoroalcane
liquefied
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92920611T
Other languages
English (en)
Other versions
ES2082507T3 (es
Inventor
Suresh Nagarbhai Mistry
Mark Gibson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27450754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2082507(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919120396A external-priority patent/GB9120396D0/en
Priority claimed from GB919120675A external-priority patent/GB9120675D0/en
Priority claimed from GB919124661A external-priority patent/GB9124661D0/en
Priority claimed from GB929203212A external-priority patent/GB9203212D0/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Application granted granted Critical
Publication of ES2082507T3 publication Critical patent/ES2082507T3/es
Publication of ES2082507T5 publication Critical patent/ES2082507T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Otolaryngology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Colloid Chemistry (AREA)

Abstract

UNA COMPOSICION DE AEROSOL PRESURIZADA QUE COMPRENDE UN HIDROFLUOROALCANO LICUADO, UN MEDICAMENTO EN POLVO DISPERSABLE EN EL Y UN POLIMERO SOLUBLE EN EL HIDROFLUOROALCANO LICUADO, EN DONDE EL POLIMERO INCLUYE UNIDADES ESTRUCTURALES PERIODICAS, ESTANDO LAS UNIDADES SELECCIONADAS ENTRE UNIDADES QUE CONTIENEN AMIDA Y UNIDADES QUE CONTIENEN ESTER DE ACIDO CARBOXILICO.
ES92920611T 1991-09-25 1992-09-23 Composiciones de aerosol presurizado. Expired - Lifetime ES2082507T5 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919120396A GB9120396D0 (en) 1991-09-25 1991-09-25 Formulations
GB919120675A GB9120675D0 (en) 1991-09-28 1991-09-28 Formulation
GB919124661A GB9124661D0 (en) 1991-11-19 1991-11-19 Formulations
GB929203212A GB9203212D0 (en) 1992-02-14 1992-02-14 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
ES2082507T3 ES2082507T3 (es) 1996-03-16
ES2082507T5 true ES2082507T5 (es) 1999-11-16

Family

ID=27450754

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92920611T Expired - Lifetime ES2082507T5 (es) 1991-09-25 1992-09-23 Composiciones de aerosol presurizado.

Country Status (28)

Country Link
US (1) US6641800B1 (es)
EP (2) EP0605578B2 (es)
JP (1) JP3142136B2 (es)
KR (1) KR100275426B1 (es)
CN (1) CN1050285C (es)
AT (1) ATE132739T1 (es)
AU (1) AU654397B2 (es)
BG (1) BG61752B1 (es)
BR (1) BR9206549A (es)
CA (1) CA2119932C (es)
CZ (1) CZ282506B6 (es)
DE (1) DE69207606T3 (es)
DK (1) DK0605578T4 (es)
ES (1) ES2082507T5 (es)
FI (1) FI110407B (es)
GR (2) GR3019098T3 (es)
HU (2) HUT67480A (es)
IL (1) IL103238A (es)
MX (1) MX9205483A (es)
MY (1) MY108309A (es)
NO (1) NO307124B1 (es)
NZ (1) NZ244439A (es)
RO (1) RO114735B1 (es)
RU (1) RU2122852C1 (es)
SK (1) SK279456B6 (es)
TW (1) TW216442B (es)
UA (1) UA41873C2 (es)
WO (1) WO1993005765A1 (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
GB9214819D0 (en) * 1992-07-13 1992-08-26 Minnesota Mining & Mfg Valve assemblies
JPH08507792A (ja) * 1993-03-17 1996-08-20 ミネソタ マイニング アンド マニュファクチャリング カンパニー ジオール−二酸から誘導される分散助剤を含むエーロゾル配合物
JP3987963B2 (ja) * 1993-03-17 2007-10-10 スリーエム カンパニー エステルー，アミド−又はメルカプトエステル−誘導分散促進剤を含むエーロゾル配合物
JP3875993B2 (ja) 1995-06-27 2007-01-31 ベーリンガー インゲルハイム コマンディトゲゼルシャフト 噴射剤を含まないエアゾールを製造するための新規で安定な医薬調製物
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6540982B1 (en) * 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
EP1274433A1 (en) * 2000-04-13 2003-01-15 Innovata Biomed Limited Medicaments for treating respiratory disorders comprising formoterol and fluticasone
EP1280520B2 (en) 2000-05-10 2018-03-21 Novartis AG Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
ME00220B (me) 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
SI1273292T1 (en) 2001-07-02 2004-12-31 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
ATE508735T1 (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
US7544177B2 (en) * 2002-01-24 2009-06-09 The Regents Of The University Of California Aerosol device to deliver bioactive agent
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
GB0328630D0 (en) * 2003-12-10 2004-01-14 Medpharm Ltd Metered dose inhalation preparations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1732527A2 (en) * 2004-03-17 2006-12-20 Mpex Pharmaceuticals, Inc. Use and administration of bacterial efflux pump inhibitors
US7994225B2 (en) * 2004-03-17 2011-08-09 Rempex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
US20070031343A1 (en) * 2005-08-04 2007-02-08 Bonfour Charles A Iii Flavored medicinal inhalant
FR2895260B1 (fr) * 2005-12-23 2009-02-20 Servier Lab Nouvelle composition pharmaceutique a base d'huile essentielle pour pulverisation nasale et/ou buccale
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
PT2425820E (pt) 2007-02-11 2015-08-04 Map Pharmaceuticals Inc Método de administração terapêutica de dhe para permitir o rápido alívio das enxaquecas ao mesmo tempo que minimiza o perfil de efeitos secundários
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
WO2009137438A2 (en) 2008-05-06 2009-11-12 Wilson-Cook Medical Inc. Apparatus and methods for delivering therapeutic agents
WO2010052466A2 (en) * 2008-11-04 2010-05-14 Cipla Limited Pharmaceutical aerosol composition
US8361054B2 (en) 2008-12-23 2013-01-29 Cook Medical Technologies Llc Apparatus and methods for containing and delivering therapeutic agents
US8118777B2 (en) 2009-05-29 2012-02-21 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
US9101744B2 (en) 2009-05-29 2015-08-11 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
US9867931B2 (en) 2013-10-02 2018-01-16 Cook Medical Technologies Llc Therapeutic agents for delivery using a catheter and pressure source
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
GB201402513D0 (en) * 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
MX381589B (es) * 2015-10-23 2025-03-12 Basf Se Formulaciones con liberación controlada de perfumes para aplicación dérmica.
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia
CN115697176A (zh) 2020-06-05 2023-02-03 库克医学技术有限责任公司 用于递送治疗剂的医疗窥镜
WO2023287654A1 (en) 2021-07-14 2023-01-19 Cook Medical Technologies, LLC Systems and methods for preventing clogging of a delivery system
US12496429B2 (en) 2022-10-18 2025-12-16 Cook Medical Technologies Llc Systems and methods for delivering pressurized fluid to a target site alone or in conjunction with therapeutic agents

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US417295A (en) * 1889-12-17 Fabriken
AT274245B (de) 1967-05-17 1969-09-10 Verfahren zur Herstellung eines Spezialklebers für Verbandmaterialien
US4025635A (en) 1972-09-06 1977-05-24 Burroughs Wellcome Co. Cyclic sulphur compounds
CA1136547A (en) * 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
EP0175671A1 (de) 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
AU601176B2 (en) 1986-03-10 1990-09-06 Kurt Burghart Benzodiazepine aerosols
US4869899A (en) * 1986-03-10 1989-09-26 Walter Burghart Pharmaceutical preparation and process for producing the same
US4752466A (en) 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL95952A0 (en) 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
IE67185B1 (en) 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
US5658549A (en) 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery

Also Published As

Publication number Publication date
IL103238A0 (en) 1993-02-21
HUT67480A (en) 1995-04-28
EP0605578B1 (en) 1996-01-10
US6641800B1 (en) 2003-11-04
ATE132739T1 (de) 1996-01-15
NO941077D0 (no) 1994-03-24
ES2082507T3 (es) 1996-03-16
HK1005564A1 (en) 1999-01-15
SK34094A3 (en) 1994-11-09
FI110407B (fi) 2003-01-31
RO114735B1 (ro) 1999-07-30
NZ244439A (en) 1994-01-26
TW216442B (en) 1993-11-21
DE69207606T3 (de) 2000-03-16
GR3032103T3 (en) 2000-03-31
DK0605578T4 (da) 2000-03-06
CZ282506B6 (cs) 1997-07-16
IL103238A (en) 1995-07-31
EP0605578A1 (en) 1994-07-13
CN1071832A (zh) 1993-05-12
BG61752B1 (bg) 1998-05-29
FI941388A0 (fi) 1994-03-25
CN1050285C (zh) 2000-03-15
AU654397B2 (en) 1994-11-03
EP0605578B2 (en) 1999-09-22
EP0534731A1 (en) 1993-03-31
GR3019098T3 (en) 1996-05-31
CA2119932A1 (en) 1993-04-01
SK279456B6 (sk) 1998-11-04
DE69207606T2 (de) 1996-06-27
DK0605578T3 (da) 1996-03-25
JPH07502262A (ja) 1995-03-09
CA2119932C (en) 2002-05-21
AU2647192A (en) 1993-04-27
BG98681A (bg) 1995-02-28
MY108309A (en) 1996-09-30
JP3142136B2 (ja) 2001-03-07
KR100275426B1 (ko) 2001-03-02
HU9400853D0 (en) 1994-06-28
RU2122852C1 (ru) 1998-12-10
DE69207606D1 (de) 1996-02-22
WO1993005765A1 (en) 1993-04-01
UA41873C2 (uk) 2001-10-15
HU210818A9 (en) 1995-08-28
CZ69594A3 (en) 1995-11-15
BR9206549A (pt) 1995-10-17
MX9205483A (es) 1993-05-01
NO941077L (no) 1994-05-18
NO307124B1 (no) 2000-02-14
FI941388L (fi) 1994-03-25

Similar Documents

Publication Publication Date Title
ES2082507T3 (es) Composiciones de aerosol presurizado.
ES2153355T3 (es) Procedimiento para la preparacion de microesferas que contienen compuestos biologicamente activos.
DK0851753T3 (da) Aerosolpræparater
EP1277467A3 (en) Non-chlorofluorocarbon aerosol formulations
RU94022269A (ru) Состав аэрозоля, находящийся под давлением
DK0918507T3 (da) Aerosolformuleringer
IL103288A (en) Topical quick breaking pharmaceutical foam composition containing felbinac
ES2130638T3 (es) Sistema para la liberacion de sustancia activa, filmogeno, vaporizable, para utilizar en las plantas.
ES2113636T3 (es) Trioles sustituidos.
AU4297089A (en) Dispersable formulation of diclofenac in free acid form
IT1265074B1 (it) Composizione farmaceutica a lento rilascio contenente come sostanza attiva un acido biliare
DK0848607T3 (da) Farmaceutiske præparater og anordninger til administration deraf
ES2062697T3 (es) Procedimiento para la incorporacion en pellets de principios activos protegidos contra la degradacion en la panza de los rumiantes.
ATE171463T1 (de) Ester aus pektin und pektinische saure
ES2064244B1 (es) Composiciones de aerosol presurizadas.
GR1001487B (el) Πεπιεσμένες συν?έσεις αεροζόλης.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 605578

Country of ref document: ES